Fig 1.
Percentages of PWID (a) and MSM (b) who endorsed willingness to use oral pre-exposure prophylaxis (PrEP), by city. The circle sizes at each city are proportionate to the percent willing to use pre-exposure prophylaxis. Estimates include sampling weights for respondent-driven sampling.
Table 1.
Characteristics of people who inject drugs and men who have sex with men who participated in a respondent-driven sampling survey across 22 sites in India between August 2016 and May 2017.
Table 2.
Reasons participants identified for being unwilling to use oral pre-exposure prophylaxis among people who inject drugs and men who have sex with men in India.
Table 3.
Reasons participants identified for being unwilling to use injectable pre-exposure prophylaxis among people who inject drugs and men who have sex with men in India.
Table 4.
Characteristics and reported risk behaviors among PWID according to willingness to use pre-exposure prophylaxis and self-perceived risk of HIV.
Table 5.
Correlates of willingness to use oral pre-exposure prophylaxis among people who inject drugs (PWID) in India.
Table 6.
Characteristics and reported risk behaviors among MSM according to willingness to use pre-exposure prophylaxis and self-perceived risk of HIV.
Table 7.
Correlates of willingness to use oral pre-exposure prophylaxis among men who have sex with men (MSM) in India.